Drug & Target Discovery (MSc)
The master's specialisation Drug & Target Discovery offers you scientific training on and hands-on experience with a range of state-of-the-art techniques, required for the discovery and characterization of novel drug targets and the synthesis and optimization of new drugs.
What does this master’s programme entail?
This master’s specialisation provides you research-oriented education into the discovery of new drug targets and safe and effective lead molecules, particularly in the field of cancer, through a combination of advanced imaging techniques (‘systems microscopy’), in vitro and in vivo model systems, organic synthesis, molecular biology and pharmacology, and computational approaches.
Read more about our Drug & Target Discovery programme.
Discover why our students choose the Bio-Pharmaceutical Sciences master's programme
Why study Bio-Pharmaceutical Sciences: Drug & Target Discovery at Leiden University?
- The Drug & Target Discovery specialisation is offered by the interdisciplinary research Division Drug Discovery and Safety of the Leiden Academic Centre for Drug Research (LACDR) focusing on a wide variety of research themes from Drug Safety Sciences and Cancer Drug Target Discovery to Computational Biology, Chem- and Bioinformatics of Drug Targets, and Synthesis of Novel Tailored Drugs.
- The strength of the programme is the research-oriented approach and the tailored programme designed for each student individually.
- You study in an internationally, top-ranked research institute.
Find more reasons to study Drug & Target Discovery at Leiden University.
Bio-Pharmaceutical Sciences: Drug & Target Discovery: the right master’s programme for you?
If you are interested in research-orientated education into advanced systems microscopy technologies and clinically relevant model systems for target and drug screening in combination with cheminformatics for development of novel effective and safe drug leads, this master’s specialisation is the right choice. Focus is on targeting hallmarks of cancer.
Read more about the entry requirements for Drug & Target Discovery.